These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 20393135

  • 1. TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes.
    Zhang Y, Lee AS, Shameli A, Geng X, Finegood D, Santamaria P, Dutz JP.
    J Immunol; 2010 May 15; 184(10):5645-53. PubMed ID: 20393135
    [Abstract] [Full Text] [Related]

  • 2. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
    Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.
    J Immunol; 1996 Nov 15; 157(10):4726-35. PubMed ID: 8906855
    [Abstract] [Full Text] [Related]

  • 3. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B.
    Eur J Immunol; 2009 Oct 15; 39(10):2716-24. PubMed ID: 19658094
    [Abstract] [Full Text] [Related]

  • 4. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D, Ho A, Odermatt B, Zakarian A, Ohashi PS, Mak TW.
    J Immunol; 1999 Apr 15; 162(8):4598-605. PubMed ID: 10201999
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
    de Jersey J, Snelgrove SL, Palmer SE, Teteris SA, Mullbacher A, Miller JF, Slattery RM.
    Proc Natl Acad Sci U S A; 2007 Jan 23; 104(4):1295-300. PubMed ID: 17229843
    [Abstract] [Full Text] [Related]

  • 7. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, Song HK, Noto LE, Jevnikar AM, Barker CF, Naji A.
    J Immunol; 1999 Jul 15; 163(2):743-50. PubMed ID: 10395666
    [Abstract] [Full Text] [Related]

  • 8. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T, Kawamura K, von Grafenstein H.
    J Immunol; 1999 Dec 01; 163(11):5770-80. PubMed ID: 10570259
    [Abstract] [Full Text] [Related]

  • 9. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS, Balasa B, Davies JD, Sarvetnick N.
    J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077
    [Abstract] [Full Text] [Related]

  • 10. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW, Barber L, Chen KE, Alters SE.
    J Autoimmun; 1995 Apr 01; 8(2):209-20. PubMed ID: 7612149
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of autoimmune diabetes by TLR2 tolerance.
    Kim DH, Lee JC, Kim S, Oh SH, Lee MK, Kim KW, Lee MS.
    J Immunol; 2011 Nov 15; 187(10):5211-20. PubMed ID: 21998452
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
    Serra P, Amrani A, Han B, Yamanouchi J, Thiessen SJ, Santamaria P.
    Proc Natl Acad Sci U S A; 2002 Nov 26; 99(24):15566-71. PubMed ID: 12432095
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 16. Development of memory-like autoregulatory CD8+ T cells is CD4+ T cell dependent.
    Shameli A, Clemente-Casares X, Wang J, Santamaria P.
    J Immunol; 2011 Sep 15; 187(6):2859-66. PubMed ID: 21824864
    [Abstract] [Full Text] [Related]

  • 17. CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.
    Wong KL, Tang LF, Lew FC, Wong HS, Chua YL, MacAry PA, Kemeny DM.
    J Immunol; 2009 Jul 01; 183(1):41-50. PubMed ID: 19535645
    [Abstract] [Full Text] [Related]

  • 18. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.
    J Immunol; 1999 Sep 01; 163(5):2960-8. PubMed ID: 10453045
    [Abstract] [Full Text] [Related]

  • 19. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
    Millet I, Wong FS, Gurr W, Wen L, Zawalich W, Green EA, Flavell RA, Sherwin RS.
    J Autoimmun; 2006 Feb 01; 26(1):7-15. PubMed ID: 16338119
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.